From October 1, 2021 to December 31, 2021, the company has repurchased 1,771,500 shares, representing 0.12% for CNY 24.24 million. With this, the company has completed the repurchase of 3,330,700 shares, representing 0.22% for CNY 45.21 million under the buyback announced on June 26, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.49 CNY | -2.64% | -2.21% | -8.99% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.99% | 3.2B | |
+45.15% | 6.38B | |
-14.00% | 4.59B | |
+9.54% | 3.39B | |
-2.41% | 2.52B | |
+50.03% | 2B | |
-6.97% | 1.7B | |
-0.31% | 1.65B | |
-10.61% | 1.58B | |
+50.00% | 1.55B |
- Stock Market
- Equities
- 600535 Stock
- News Tasly Pharmaceutical Group Co., Ltd
- Tranche Update on Tasly Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on June 26, 2021.